Clinical trials showed the multiple sclerosis treatment, Briumvi, reduced relapse rates by over 50% and shut down active inflammation by 97%, compared to pills, doctors said.
Exclusive, subscriber-only content and weekly email newsletters.Full access on your desktop, tablet and mobile device.Original reporting that provides diverse perspectives on news and issues of today.Are you a subscriber.
Exclusive, subscriber-only content and weekly email newsletters.Full access on your desktop, tablet and mobile device.Original reporting that provides diverse perspectives on news and issues of today.Are you a subscriberUnited States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
USA TODAY
Read more »
USA TODAY
Read more »
Corporate diversity database: A USA TODAY investigative series inside the nation’s most powerful companiesCorporate leaders promised to improve diversity after George Floyd&39;s murder. USA TODAY tracks the progress in this series and with a reader database.
Read more »
USA TODAY
Read more »
USA TODAY
Read more »
USA TODAY
Read more »